288 related articles for article (PubMed ID: 15919510)
1. Donor MHC class I peptides in conjunction with self-epitopes induce donor-specific tolerance in a dose-dependent manner but unable to abrogate chronic rejection.
Semiletova NV; Shen XD; Feldman DM; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
Transplant Proc; 2005 May; 37(4):1937-9. PubMed ID: 15919510
[TBL] [Abstract][Full Text] [Related]
2. Posttransplant administration of allochimeric major histocompatibility complex class-I-molecules induces true transplantation tolerance.
Semiltova N; Shen XD; Fishbein MC; Gao F; Slomowitz SJ; Jiao Q; Mukherjee K; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
Transplantation; 2003 Feb; 75(4):550-3. PubMed ID: 12605125
[TBL] [Abstract][Full Text] [Related]
3. Class I MHC allochimeric presentation of composite immunogenic and self epitopes induces tolerance to genetically diverse rat strains.
Semiletova NV; Shen XD; Feldman DM; Gao F; Mhoyan A; Liu D; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
Cell Immunol; 2007 Jul; 248(1):48-58. PubMed ID: 17936255
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
[TBL] [Abstract][Full Text] [Related]
5. Localization of cryptic tolerogenic epitopes in the alpha1-helical region of the RT1.Au alloantigen.
Wang M; Stepkowski SM; Yu J; Wang M; Kahan BD
Transplantation; 1997 May; 63(10):1373-9. PubMed ID: 9175796
[TBL] [Abstract][Full Text] [Related]
6. Allochimeric therapy induces unique regulatory T cells that mitigate chronic rejection.
Semiletova NV; Shen XD; Slomowitz SJ; Baibakov B; Feldman DM; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
Transplant Proc; 2005; 37(1):35-6. PubMed ID: 15808538
[TBL] [Abstract][Full Text] [Related]
7. Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720.
Chueh SC; Tian L; Wang M; Wang ME; Stepkowski SM; Kahan BD
Transplantation; 1997 Nov; 64(10):1407-14. PubMed ID: 9392303
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy.
Sayegh MH; Perico N; Gallon L; Imberti O; Hancock WW; Remuzzi G; Carpenter CB
Transplantation; 1994 Jul; 58(2):125-32. PubMed ID: 8042230
[TBL] [Abstract][Full Text] [Related]
9. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
10. Intensity of transplant chronic rejection correlates with level of graft-infiltrating regulatory cells.
Semiletova NV; Shen XD; Baibakov B; Andakyan A
J Heart Lung Transplant; 2010 Mar; 29(3):335-41. PubMed ID: 20080050
[TBL] [Abstract][Full Text] [Related]
11. Induction of indirect donor-specific hyporesponsiveness by transportal RT1-peptide pulse in rat skin transplantation.
Yamamura M; Yagi T; Iwagaki H; Mitsuoka N; Jie L; Sheng SD; Matsuda H; Sadamori H; Inagaki M; Tanaka N
Transpl Int; 2003 Aug; 16(8):451-5. PubMed ID: 12719799
[TBL] [Abstract][Full Text] [Related]
12. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression.
Gallon L; Watschinger B; Murphy B; Akalin E; Sayegh MH; Carpenter CB
Transplantation; 1995 Feb; 59(4):612-6. PubMed ID: 7878766
[TBL] [Abstract][Full Text] [Related]
13. Allochimeric class I MHC molecules prevent chronic rejection and attenuate alloantibody responses.
Singer JS; Mhoyan A; Fishbein MC; Shen XD; Gao F; Zhao D; Coito AJ; Reemtsen BL; Amersi F; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
Transplantation; 2001 Oct; 72(8):1408-16. PubMed ID: 11685113
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression.
Oluwole SF; Jin MX; Chowdhury NC; Ohajekwe OA
Transplantation; 1994 Nov; 58(10):1077-81. PubMed ID: 7974714
[TBL] [Abstract][Full Text] [Related]
15. Use of allochimeric proteins to mitigate graft-versus-host and host-versus-graft immune responses to rat small bowel allografts.
Okamoto M; Stepkowski SM; Wang M; Kahan BD
Transplantation; 2000 Oct; 70(7):1060-7. PubMed ID: 11045643
[TBL] [Abstract][Full Text] [Related]
16. Induction of transplantation tolerance by chimeric donor/recipient class I RT1.Aa molecules.
Ghobrial RR; Hamashima T; Wang ME; Wang M; Stepkowski SM; Kahan BD
Transplantation; 1996 Oct; 62(7):1002-10. PubMed ID: 8878396
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
[TBL] [Abstract][Full Text] [Related]
18. Identification of early tolerance regulator genes induced by allochimeric therapy using microarray-based genomewide scan.
Liu D; Shen XD; Fang Z; Gao F; Semiletova N; Cao MJ; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
Transplant Proc; 2005 May; 37(4):1942-3. PubMed ID: 15919512
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic core amino acids of an immunodominant allopeptide are important for MHC binding and TCR recognition.
Sitaru AG; Timmermann W; Ulrichs K; Otto C
Hum Immunol; 2004 Aug; 65(8):817-25. PubMed ID: 15336783
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of allo-recognition. Recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells.
Watschinger B; Gallon L; Carpenter CB; Sayegh MH
Transplantation; 1994 Feb; 57(4):572-6. PubMed ID: 8116044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
